Is Fertility Affected in Women of Childbearing Age with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder?

(2020) Is Fertility Affected in Women of Childbearing Age with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder? Journal of Molecular Neuroscience. pp. 1829-1835. ISSN 0895-8696

[img]
Preview
Text
13562.pdf

Download (276kB) | Preview

Abstract

Multiple sclerosis (MS) is a chronic immune-mediated demyelinating disease of the central nervous system (CNS), which is more prevalent among women of childbearing age. Neuromyelitis optica spectrum disorder (NMOSD) is a severe autoimmune disease of the CNS with similar prevalence features to MS and has recently been considered a different entity from MS. Measuring ovarian reserve is one way of evaluating fertility. Anti-Mullerian hormone (AMH) is a peptide hormone produced by ovarian granulosa cells of early follicles and is considered to be a marker for ovarian reserve. With MS and NMOSD predominance in young women, the present study aimed to address the possibility of these diseases affecting fertility by measuring AMH levels in MS and NMOSD patients and comparing it with healthy controls. The present study included 23 relapsing-remitting MS (RRMS) patients, 23 seronegative NMOSD patients, and 23 healthy age-matched controls between 18 and 45 years of age. Serum samples of the three groups were collected, and the AMH levels were measured with AMH Gen II Enzyme-Linked Immunosorbent Assay, Beckman Coulter kit. In the present study, the AMH levels did not differ significantly between the groups (p = 0.996). The mean AMH in the RRMS group was 3.59 +/- 0.55 ng/ml compared with the mean of 3.60 +/- 0.50 ng/ml in healthy controls. The mean AMH levels in the NMOSD group were 3.66 +/- 0.61 ng/ml. Lower levels of AMH were found to be negatively associated with annualized relapse rate (in both groups of patients) and MS severity score. However, the difference was not significant. In NMOSD patients, the serum levels of AMH were negatively associated with disease duration (r = - 0.42,p = 0.023). There had been a significant negative correlation between mean AMH serum levels with Expanded Disability Status Scale (EDSS) at the time of diagnosis and at the time of study in the NMOSD group (r = - 0.402,p = 0.03 andr = - 0.457,p = 0.014, respectively). There was not a significant difference in mean serum AMH levels between RRMS and NMOSD patients compared with that of healthy controls. Further studies with larger sample sizes should be conducted, which take more variables affecting fertility in women with either RRMS or NMOSD into account to put an end to the controversial issue of fertility in this area.

Item Type: Article
Keywords: Multiple sclerosis Neuromyelitis optica spectrum disorder Devic's disease Anti-Mullerian hormone Fertility Pregnancy ANTI-MULLERIAN HORMONE OVARIAN RESERVE PREGNANCY MANAGEMENT DIAGNOSIS MITOXANTRONE FEMALE SAFETY SEX
Subjects: WL Nervous System > WL 200-405 Central Nervous System. Disorders. Therapeutics
Divisions: Faculty of Medicine > Departments of Clinical Sciences > Department of Neurology
Faculty of Medicine > Student Research Committee
Isfahan Neurosciences Research Center
Page Range: pp. 1829-1835
Journal or Publication Title: Journal of Molecular Neuroscience
Journal Index: ISI
Volume: 70
Number: 11
Identification Number: https://doi.org/10.1007/s12031-020-01576-x
ISSN: 0895-8696
Depositing User: Zahra Otroj
URI: http://eprints.mui.ac.ir/id/eprint/13562

Actions (login required)

View Item View Item